. . "A trivalent polysaccharide-protein conjugate vaccine, capable of eliciting serum antibodies to groups A, B, and C meningococcal meningitis and thereby preventing most of the systemic infections, including meningitis, caused by Neisseria meningitidis, may be produced by this method using the above-described conjugates and a group A meningococcal conjugate." . .